Cost-effectiveness of telehealthcare to patients with chronic obstructive pulmonary disease: results from the Danish 'TeleCare North cluster-randomised trial

Conclusions Telehealthcare is unlikely to be a cost-effective addition to usual care, if it is offered to all patients with chronic obstructive pulmonary disease and if the willingness-to-pay threshold values from the National Institute for Health and Care Excellence are applied. Trial registration Clinicaltrials.gov, NCT01984840, 14 November 2013.

http://bmjopen.bmj.com/cgi/content/short/7/5/e014616?rss=1

Source: BMJ Open - May 17, 2017 Category: General Medicine Authors: Witt Udsen, F., Lilholt, P. H., Hejlesen, O., Ehlers, L. Tags: Open access, Health economics Research Source Type: research

More News: Chronic Obstructive Pulmonary | Denmark Health | Economics | General Medicine